Breakthrough Victoria Fund
Atmo Biosciences’ revolutionary gas-sensing capsule, supported by Breakthrough Victoria, transforms gastrointestinal diagnosis with real-time gut data, providing a non-invasive and patient-friendly approach to FGID diagnosis.